Editas Medicine, Inc. - Special Call
Source: SeekingAlpha
2025-09-02 11:14:24 ET
Editas Medicine, Inc. - Special Call
Company Participants
Gilmore O’Neill - President, CEO & Director
Linda Burkly - Executive VP & Chief Scientific Officer ...
Read the full article on Seeking Alpha
For further details see:
Editas Medicine, Inc. - Special Call
Editas Medicine Inc.
NASDAQ: EDIT
EDIT Trading
2.59% G/L:
$2.82 Last:
212,565 Volume:
$2.75 Open:
EDIT Latest News
March 27, 2026 07:00:00 am
Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference
EDIT Stock Data
$174,737,401
95,568,668
0.4%
71
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
